Beata Dobracka
Wroclaw, DS 53228, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients.
Journal: Expert review of anti-infective therapy
Published: May 09, 2024
Direct-acting antivirals in women of reproductive age infected with hepatitis C virus.
Journal: Journal of viral hepatitis
Published: January 08, 2024
Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?
Journal: Antiviral research
Published: September 07, 2023
Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
Journal: Journal of clinical medicine
Published: June 13, 2021
Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study.
Journal: World journal of gastroenterology
Published: January 26, 2021
Real-world direct-acting antiviral treatment in kidney transplant and hemodialysis patients: the EpiTer-2 multicenter observational study.
Journal: Annals of gastroenterology
Published: September 13, 2020
Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience?
Journal: Journal of gastroenterology and hepatology
Published: September 10, 2020
Real-world effectiveness and safety of direct-acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi-Ter2 Study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 30, 2020
Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA.
Journal: Expert review of anti-infective therapy
Published: June 16, 2020
Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection.
Journal: Polish archives of internal medicine
Published: February 08, 2020
Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.
Journal: Journal of gastroenterology and hepatology
Published: September 05, 2019
Last Updated: 09/26/2026